Sonder - Your Local Health News - Jan/Feb 2020
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
●<br />
●<br />
●<br />
●<br />
dexamethasone suppression test<br />
Phaeochromocystoma – 24-hour urinary<br />
metanephrines and normetanephrines<br />
Aldosteronoma – plasma aldosterone:renin<br />
ratio<br />
Sex hormones – very rare. Test only if patient<br />
display virilisation features. If present, be<br />
suspicious for adrenal malignancy.<br />
(Confounders – drugs e.g. steroids, ACE<br />
inhibitors, SSRIs can interfere with test results<br />
and need to be withheld temporarily)<br />
3. How big is the lesion and is it growing?<br />
●<br />
Size is an important predictor for malignancy.<br />
Numerous studies have shown that the risk for<br />
adrenal malignancy is approximately 5-10%<br />
for lesions 4-6 cm, and 15-20% for lesions >6<br />
cm. Therefore, any lesions larger than 4cm<br />
should be referred to an endocrine surgeon for<br />
consideration of surgery.<br />
discharged within 24 hours with minimal pain.<br />
EXTERNAL NEWS<br />
As there is no breach of the peritoneal cavity,<br />
issues such as post-operative ileus and adhesion<br />
formation are avoided.<br />
Open adrenalectomy is usually reserved for<br />
adrenocortical carcinoma, metastases, or large<br />
lesion to minimize the risk of breaching the tumour<br />
and causing spillage and seeding of the cancer<br />
cells.<br />
Whilst size is not an independent predictor for<br />
open surgery (factors e.g. location of tumour and<br />
body habitus of the patient play a significant role),<br />
it is usually very challenging to resect an adrenal<br />
tumour endoscopically when larger than 8 cm.<br />
Follow-up<br />
For benign adrenal tumours that are not resected,<br />
it is reasonable to obtain a non-contrast CT in 6-12<br />
months to assess for growth in size.<br />
●<br />
If an adrenal incidentaloma is 20% or >5mm per year<br />
should be referred to an endocrine surgeon for<br />
consideration of resection. Lipid rich (Hounsfield unit<br />